OGI — Organigram Global Share Price
0.000.00%
Last trade - 00:00- CA$197.99m
- CA$195.94m
- CA$159.84m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.61 | ||
| Price to Tang. Book | 0.82 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.19 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -7.57% | ||
| Return on Equity | -18.11% | ||
| Operating Margin | -18.69% | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 86.8 | 79.16 | 145.81 | 161.64 | 159.84 | 237.86 | 275.95 | 14.73% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Directors
- Peter Amirault NEC (61)
- Beena Goldenberg CEO (59)
- Derrick West CFO (54)
- James Fletcher CEX
- Megan Mccrae SVP
- Nathalie Batten VOP
- Julie Chamberlain VPR
- Borna Zlamalik VPR
- Paolo De Luca OTH (40)
- Timothy Emberg OTH
- Helen Martin OTH
- Dexter John IND (52)
- Geoffrey Machum IND (61)
- Ken Manget IND (59)
- Sherry Porter IND (66)
- Stephen Smith IND (64)
- Marni Wieshofer IND (59)
- Last Annual
- September 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 6th, 2016
- Public Since
- November 24th, 2011
- No. of Employees
- 1,093
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 133,779,483
- Address
- 35A English Dr, MONCTON, E1E 3X3
- Web
- https://www.organigram.ca/
- Phone
- +1 5063841571
- Auditors
- PKF O'Connor Davies
Upcoming Events for OGI
Q3 2025 OrganiGram Holdings Inc Earnings Release
Similar to OGI
Andlauer Healthcare
Toronto Stock Exchange
Avant Brands
Toronto Stock Exchange
dentalcorp Holdings
Toronto Stock Exchange
Extendicare
Toronto Stock Exchange
Lifespeak
Toronto Stock Exchange
FAQ
What is the Organigram Global share price?
As of Today at 22:28 UTC, shares in Organigram Global are trading at CA$1.48. This share price information is delayed by 15 minutes.
How has the Organigram Global share price performed this year?
Shares in Organigram Global last closed at CA$1.48 and the price had moved by -41.5% over the past 365 days. In terms of relative price strength the Organigram Global share price has underperformed the Toronto Stock Exchange 300 Composite Index by -47.27% over the past year.
What are the analyst and broker recommendations for Organigram Global?
The overall consensus recommendation for Organigram Global is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Organigram Global dividend yield?
Organigram Global does not currently pay a dividend.
Does Organigram Global pay a dividend?
Organigram Global does not currently pay a dividend.
When does Organigram Global next pay dividends?
Organigram Global does not currently pay a dividend.
How do I buy Organigram Global shares?
To buy shares in Organigram Global you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Organigram Global?
As of the previous close price of CA$1.48, shares in Organigram Global had a market capitalisation of CA$197.99m.
Where are Organigram Global shares listed?
Here are the trading details for Organigram Global:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: OGI
What kind of share is Organigram Global?
Based on an overall assessment of its quality, value and momentum Organigram Global is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Organigram Global share price forecast for 2025?
The analyst consensus target price for shares in Organigram Global is CA$2.83. That is 91.22% above the last closing price of CA$1.48.
Analysts covering Organigram Global currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.21 for the next financial year.
Find out moreWhat is the trend in the Organigram Global share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Organigram Global. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -38.01%.
As of the last closing price of CA$1.48, shares in Organigram Global were trading -30.84% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Organigram Global PE Ratio?
The Organigram Global PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$1.48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Organigram Global?
Organigram Global's management team is headed by:
- Peter Amirault - NEC
- Beena Goldenberg - CEO
- Derrick West - CFO
- James Fletcher - CEX
- Megan Mccrae - SVP
- Nathalie Batten - VOP
- Julie Chamberlain - VPR
- Borna Zlamalik - VPR
- Paolo De Luca - OTH
- Timothy Emberg - OTH
- Helen Martin - OTH
- Dexter John - IND
- Geoffrey Machum - IND
- Ken Manget - IND
- Sherry Porter - IND
- Stephen Smith - IND
- Marni Wieshofer - IND